Evidence map›Paper›PMID 26214836›Full record

ArticleNature medicine2015

The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment.

Xuan Zhang, Dongya Zhang, Huijue Jia, Qiang Feng, Donghui Wang, Di Liang, Xiangni Wu, Junhua Li, Longqing Tang, Yin Li and 38 more

5 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 971 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
971citing papers in PubMed, 8 pooled it
52.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03058900 nacompletednot on this mapstarted 2017, after this paper: background citation

Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Peripheral Psoriatic Arthritis: a 6-month, Double-Blind, Randomized, Placebo-Controlled Trial

TypeinterventionalSponsorOdense University HospitalRan2017 to 2020Enrolled31ConditionsPsoriatic ArthritisArmsFecal microbiota transplantation (FMT), Drug: Placebo (saline), Methotrexate (MTX)
NCT03775824 completednot on this mapstarted 2016, after this paper: background citation

Faecal Analyses in Rheumatoid Arthritis Therapy: An Prospective Observational Study of the Intestinal Microbiome in Patients With Rheumatoid Arthritis Receiving Immunosuppressive Therapy

TypeobservationalSponsorRegion SkaneRan2016 to 2019Enrolled50ConditionsRheumatoid ArthritisArmsMTX start, TNF start
NCT05329571 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Microbiome Correlates of Dietary Interventions in Patients With Fibromyalgia and Their Association With Symptom Modification

TypeinterventionalSponsorMcGill University Health Centre/Research Institute of the McGill University Health CentreRan2021 to 2024Enrolled50ConditionsFibromyalgia, Diet, Gluten-FreeArmsLow-FODMAP diet, Gluten-free Diet, Control group
NCT06322784 nacompletednot on this mapstarted 2022, after this paper: background citation

Effects of Dietary Fiber (Oat Bran) Intervention on Inflammation, Intestinal Flora, Disease Activity and Quality of Life in Patients With Rheumatoid Arthritis

TypeinterventionalSponsorShenzhen People's HospitalRan2022 to 2024Enrolled25ConditionsRheumatoid ArthritisArmsOat bran (dietary fiber)
NCT06450821 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

PROSpECT-PRIOR-2-CHEMO: A Feasibility RCT of Novel Dental Intervention PRIOR[Proactive Intensive Oral Review & Treatment] in Patients Scheduled for Chemotherapy for Myeloma-ASCT & Hematological Cancers to Mitigate Chemotherapy Complications

TypeinterventionalSponsorUniversity of LeedsRan2024 to 2026Enrolled60ConditionsOncology, Periodontitis, Myeloma, Oral MucositisArmsPRIOR [Proactive Intensive Oral Review & Treatment]
3 · Its place in the literature

Who cites it

971 citing papers in PubMed, 8 syntheses or guidelines pooled it, 1,695 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Oral virome in health and disease.Journal of the American Dental Association (1939) · 2026
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

911 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

48 authors at 6 institutions in 5 countries.

Xuan ZhangDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Dongya Zhang1] BGI-Shenzhen, Shenzhen, China. [2] Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research, BGI-Shenzhen, Shenzhen, China.
Huijue Jia1] BGI-Shenzhen, Shenzhen, China. [2] Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research, BGI-Shenzhen, Shenzhen, China.ORCID 000000023592126X
Qiang Feng1] BGI-Shenzhen, Shenzhen, China. [2] Shenzhen Engineering Laboratory of Detection and Intervention of Human Intestinal Microbiome, BGI-Shenzhen, Shenzhen, China. [3] Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Donghui Wang1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Di LiangDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xiangni WuDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Junhua Li1] BGI-Shenzhen, Shenzhen, China. [2] Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research, BGI-Shenzhen, Shenzhen, China. [3] School of Bioscience and Biotechnology, South China University of Technology, Guangzhou, China.
Longqing TangBGI-Shenzhen, Shenzhen, China.
Yin LiBGI-Shenzhen, Shenzhen, China.
Zhou LanBGI-Shenzhen, Shenzhen, China.
Bing ChenBGI-Shenzhen, Shenzhen, China.
Yanli LiBGI-Shenzhen, Shenzhen, China.
Huanzi ZhongBGI-Shenzhen, Shenzhen, China.
Hailiang XieBGI-Shenzhen, Shenzhen, China.
Zhuye JieBGI-Shenzhen, Shenzhen, China.
Weineng ChenBGI-Shenzhen, Shenzhen, China.
Shanmei TangBGI-Shenzhen, Shenzhen, China.
Xiaoqiang Xu1] BGI-Shenzhen, Shenzhen, China. [2] BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, China.
Xiaokai Wang1] BGI-Shenzhen, Shenzhen, China. [2] BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, China.
Xianghang CaiBGI-Shenzhen, Shenzhen, China.
Sheng Liu1] BGI-Shenzhen, Shenzhen, China. [2] BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, China.
Yan Xia1] BGI-Shenzhen, Shenzhen, China. [2] BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, China.
Jiyang Li1] BGI-Shenzhen, Shenzhen, China. [2] Qingdao University-BGI Joint Innovation College, Qingdao University, Qingdao, China.
Xingye QiaoDepartment of Mathematical Sciences, Binghamton University, State University of New York, Binghamton, New York, USA.
Jumana Yousuf Al-Aama1] BGI-Shenzhen, Shenzhen, China. [2] Princess Al-Jawhara Al Brahim Centre of Excellence in Research of Hereditary Disorders (PACER-HD), Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Hua ChenDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li WangDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qing-Jun WuDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Fengchun ZhangDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wenjie ZhengDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yongzhe LiDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Mingrong ZhangBGI-Shenzhen, Shenzhen, China.
Guangwen LuoBGI-Shenzhen, Shenzhen, China.
Wenbin XueBGI-Shenzhen, Shenzhen, China.
Liang Xiao1] BGI-Shenzhen, Shenzhen, China. [2] Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research, BGI-Shenzhen, Shenzhen, China.
Jun LiBGI-Shenzhen, Shenzhen, China.
Wanting ChenBGI-Shenzhen, Shenzhen, China.
Xun XuBGI-Shenzhen, Shenzhen, China.
Ye YinBGI-Shenzhen, Shenzhen, China.
Huanming YangBGI-Shenzhen, Shenzhen, China.
Jian WangBGI-Shenzhen, Shenzhen, China.
Karsten Kristiansen1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Liang LiuMacau University of Science and Technology, Taipa, Macau, China.
Ting LiMacau University of Science and Technology, Taipa, Macau, China.
Qingchun HuangDepartment of Rheumatology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China.
Yingrui LiBGI-Shenzhen, Shenzhen, China.
Jun Wang1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of Copenhagen, Copenhagen, Denmark. [3] Macau University of Science and Technology, Taipa, Macau, China.
BGI Group (China) · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNMacau University of Science and Technology · MOBinghamton University · USGuangdong Provincial Hospital of Traditional Chinese Medicine · CNUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We carried out metagenomic shotgun sequencing and a metagenome-wide association study (MGWAS) of fecal, dental and salivary samples from a cohort of individuals with rheumatoid arthritis (RA) and healthy controls. Concordance was observed between the gut and oral microbiomes, suggesting overlap in the abundance and function of species at different body sites. Dysbiosis was detected in the gut and oral microbiomes of RA patients, but it was partially resolved after RA treatment. Alterations in the gut, dental or saliva microbiome distinguished individuals with RA from healthy controls, were correlated with clinical measures and could be used to stratify individuals on the basis of their response to therapy. In particular, Haemophilus spp. were depleted in individuals with RA at all three sites and negatively correlated with levels of serum autoantibodies, whereas Lactobacillus salivarius was over-represented in individuals with RA at all three sites and was present in increased amounts in cases of very active RA. Functionally, the redox environment, transport and metabolism of iron, sulfur, zinc and arginine were altered in the microbiota of individuals with RA. Molecular mimicry of human antigens related to RA was also detectable. Our results establish specific alterations in the gut and oral microbiomes in individuals with RA and suggest potential ways of using microbiome composition for prognosis and diagnosis.

Indexed as

MicrobiotaAntirheumatic AgentsArthritis, RheumatoidC-Reactive ProteinHumansIntestinesMetagenomeMouthSalivaAntirheumatic AgentsC-Reactive Protein

Identifiers

PMID26214836
OpenAlexW2113552312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.